Tiziana Life Sciences (TILS)

 

TILS Share PerformanceMore

52 week high240.00 25/04/17
52 week low102.05 08/06/17
52 week change -69.00 (-33.41%)
4 week volume157,975 23/12/17

Latest NewsMore

Tiziana Life Sciences places news shares

Tiziana Life Sciences has raised 150,000 via a share issue at 150p per share Each placing share had a warrant attached entitl...

Placing

RNS Number: 9305B Tiziana Life Sciences PLC 16 January 2018 Tiziana Life Sciences plc (" Tiziana " or the " Company ") Placing to raise 150,000 and issue of equity London, January 16, 2018 - Tiziana Life Sciences plc (AIM: TILS), a clinical stage biotechnology company developing targeted drugs for cancer and autoimmune diseases, today announces that it has raised...

Placing and Issue of Equity

RNS Number: 4366Z Tiziana Life Sciences PLC 15 December 2017 Tiziana Life Sciences plc (" Tiziana " or the " Company ") Placing to raise 200,000 and issue of equity London, December 15, 2017 - Tiziana Life Sciences plc (AIM: TILS), a clinical stage biotechnology company developing targeted drugs for cancer and autoimmune diseases, today announces that it has r...

Tiziana Life Sciences says cancer drug well-tolerated

Tiziana Life Sciences said an independent analysis has concluded that treatment with cancer drug Milciclib was safe and w...

Milciclib Phase 2a Trial Update

RNS Number: 7502Y Tiziana Life Sciences PLC 08 December 2017 Tiziana Life Sciences plc ("Tiziana" or the "Company") Tiziana Life Sciences Announces Safety of Milciclib in a Phase 2a Trial in Unresectable or Metastatic Hepatocellular Carcinoma (HCC) Patients Demonstration of safety, a pre-requisite to initiate a Phase 2b trial evaluating combination of Milcic...

Tiziana Life Sciences issues shares

Tiziana Life Sciences has raised 275,000 from a share placement. New shares in the company were issued at 150p each. Plac...

Placing

RNS Number: 5262X Tiziana Life Sciences PLC 27 November 2017 Tiziana Life Sciences plc (" Tiziana " or the " Company ") Placing to raise 275,000 London, November 27, 2017 - Tiziana Life Sciences plc (AIM: TILS), a clinical stage biotechnology company developing targeted drugs for cancer and autoimmune diseases, today announces that it has raised 275,000 by ...

Tiziana rare cancer drug meets endpoints

Tiziana Life Sciences' drug milciclib, a small molecular pan-inhibitor of cyclin dependent kinases (CDKs), has met its prim...

Fundamental DataMore

EPS-7.7
Dividend yield0 %

Latest discussion posts More

  • Top up

    Bad news this am but couldn't resist a 500 top up at 115.06.
    8-Jun-2017
    osammyboy
  • Fundraise

    Beaufort Securities's note out this morning on Research Tree: "Tiziana progressed well during the FY2015. It strengthened its portfolio by acquiring exclusive licence for both ...
    8-Jun-2016
    Simbr
  • no buying

    With sp @110 and bid @ 115 I tried buying 2500 online at Barclays. Quoted 187.4 Obviously buying is being discouraged for whatever reason
    28-Apr-2016
    osammyboy

Users' HoldingsMore

Users who hold Tiziana Life Sciences also hold..

Codes & Symbols

ISINGB00BKWNZY55
SymbolsTILS, LSE:TILS, TILS.L, TILS:LN, LON:TILS, XLON:TILS

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account